COVID-19 Updates
From the Journals
COVID vaccines lower risk of serious illness in children
“The findings in this report support the recommendation for COVID-19 vaccination for all children aged ≥6 months and highlight the importance of...
News from the FDA/CDC
New CDC advisory once again flags BA.2.86 COVID variant
The variant accounted for nearly 9% of cases during the 2-week period ending Nov. 25, up from 3% during the previous 2 weeks.
From the Journals
Unexplained collapse unveils rare blood disorder
Acquired TTP often appears to arise in connection with either an immune trigger, such as a viral infection, or immune dysregulation associated...
Conference Coverage
AI tool perfect in study of inflammatory diseases
A model that combines machine learning with clinical cues could help clinicians easily differentiate MIS-C from typhus, a new study found.
From the Journals
Long COVID and mental illness: New guidance
“Long COVID is real, and mental health conditions do not cause long COVID.”
From the Journals
Sensory comeback: New findings show the path to smell and taste recovery after COVID
“... There are still people suffering from it. ... It really has a significant psychological impact.”
From the Journals
A new long COVID explanation: Low serotonin levels?
The study found lower serotonin levels in long COVID patients, compared with patients who were diagnosed with acute COVID-19 but who fully...
Feature
Second infection hikes long COVID risk: Expert Q&A
There are people who think, “This is a nothing-burger anymore,” or “It’s not an issue anymore.” It’s still happening with the current variants.
From the Journals
Serious mental illness tied to 50% higher all-cause mortality risk after COVID
“From a public health perspective, our study has emphasized the need for early and timely preventative interventions (e.g. vaccination) for the...
From the Journals
Nirmatrelvir-ritonavir ineffective at reducing most post-COVID conditions
However, thromboembolic events were reduced.
News
mRNA vaccine cuts COVID-related Guillain-Barré risk
“While Guillain-Barré is extremely rare, people should be aware that having a COVID infection can increase their risk of developing the disorder,...